Replies to post #3172 on VistaGen Therapeutics Inc (VTGN)

[Johnny_C]

I don’t expect NIH results till Q2, I could be wrong though.

The financing was to start 2adjunctive and if that hasn’t started I would expect this soon.

I also expect analysts to start covering VTGN, although that might not happen until NIH is out.

The patent, FDA fasttrack and funding are all positives. The warrants are like a future underwriting, all positves